Myeloperoxidase (MPO) stool, urine ELISA
- Regulatory Status
- EU: CE
- Kit size
- 12 x 8
- Method
- ELISA
- Incubation time
- 3 x 1 h, 1 x 5 min
- Standard range
- 1.56 - 100 ng/mL
- Specimen / Volumes
- 100 µL stool, urine
- Substrate / isotope
- TMB 450 nm
Enzyme immunoassay for the in-vitro determination of Myeloperoxidase (MPO) in human urine and stool.
The granules of neutrophils (approx. 70% of the white blood cells) contain a large number of different enzymes. Myeloperoxidase (MPO) catalyzes the oxidation of substances through H2O2. The MPO H2O2–system has a toxic effect on many microorganisms such as bacteria, fungi, viruses and mycoplasma. The efficiency of the bacteria-destructive Myeloperoxidase H2O2–system is increased by PMN-Elastase. MPO determination in the, stool reflects the inflammatory activity of Crohn´s disease or ulcerative colitis.
Indication
- Marker for inflammatory activities in the gastrointestinal tract
- Renal transplant rejection
- Oxidative stress
- For the differentiation between allergic and infectious asthma
For concrete data please consult the Instruction for Use in the download box on the top right side.
Our Product Families
Our comprehensive immunoassay portfolio includes a number of specialty diagnostic immunoassays for endocrinology, immunology and autoimmunity, as well as for diagnosis of multiple infectious diseases. We are pioneers and market leaders in saliva diagnostics, with over 40 years of experience supplying a broad portfolio of luminescence- and ELISA-based tests, including our highly acclaimed HMGB1 and MuSK-Ab ELISAs.
And as experts in laboratory automation, we can support our customers with the protocols for open ELISA platforms, such as the Freedom EVOlyzer or Thunderbolt®.
All products are only available for sale to laboratory professionals and may not be available in all countries. Availability and regulatory status may vary across regions depending on local country-specific registration. Please always read and follow the instructions for use.
All of our assays have been designed and manufactured to meet the highest global regulatory requirements and quality standards. Tecan is certified under ISO 9001:2015, ISO 13485:2016 and is audited by a notified body according to Medical Device Single Audit Program (MDSAP).
This is who we are.
As part of the Tecan Group, we have a leading market position in diagnostics and research, with over 40 years of experience in the development, manufacture and supply of enzyme-, radiolabel- and luminescence-based immunoassays.
Our range of high-quality immunoassays is supported by a diverse portfolio of automated solutions, making us the perfect partner for you and your customers.
Happy to help.
At Tecan, we are driven to improve people’s lives and health.